BMS-823778

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBMS-823778
Drug Alias NameBMS-823778
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action11-beta-hydroxysteroid dehydrogenase inhibitors
Targets11-beta-hydroxysteroid dehydrogenase
Therapy Area/IndicationsHypercholesterolemiaDyslipidemiasDiabetes Mellitus, Type 2 +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSweden +[9] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol Myers Squibb SrlcompanyBristol-Myers Squibb (China) Investment Co LtdBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaDyslipidemiasDiabetes Mellitus, Type 2 +[6] 

Other Information

ATC CodeN/A
Related LinksN/A